Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Aug 25, 2016, 09:00 ET Renew Research Center Conducting Study on the Effects of Better Blood Flow

Renew Research, LLC announced that the Renew Research Center is conducting groundbreaking clinical research to see if the FDA-cleared ECP device...


Aug 25, 2016, 09:00 ET PinnacleHealth Implants Aortic Valve to First Patients in United States after FDA Approval for Commercial Use

 Today, PinnacleHealth became the first hospital in the country to implant the EDWARDS INTUITY Elite valve, a rapid deployment device...


Aug 25, 2016, 09:00 ET Boehringer Ingelheim and Duke Clinical Research Institute Expand Collaboration to Create Largest Patient Registry for Idiopathic Pulmonary Fibrosis (IPF)

Boehringer Ingelheim Pharmaceuticals, Inc. and the Duke Clinical Research Institute (DCRI) announced today the expansion of the Idiopathic...


Aug 25, 2016, 08:00 ET Denali Therapeutics Announces First Clinical Trial Application, Key Collaborations And $130M Series B

 Denali Therapeutics Inc. ("Denali") today announced several critical milestones in the company's growth, including its first Clinical Trial...


Aug 25, 2016, 08:00 ET Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin

 Armetheon, Inc., a specialty pharmaceutical company developing novel small molecule drugs for cardiovascular diseases, today announced results...


Aug 25, 2016, 07:30 ET Mallinckrodt Receives FDA Fast-Track Designation for Synacthen® Depot IND Application

 Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced the U.S. Food and Drug Administration (FDA)...


Aug 25, 2016, 07:00 ET Pivotal Study Results Published in New England Journal of Medicine (NEJM) Confirm Safety and Efficacy of INSIGHTEC's Exablate Neuro System for the Treatment of Essential Tremor

 INSIGHTEC, the leader in MR-guided Focused Ultrasound (MRgFUS) therapy, today announced that the New England Journal of Medicine (NEJM) has...


Aug 25, 2016, 06:30 ET Mylan and Biocon Announce Regulatory Submission for Proposed Biosimilar Trastuzumab Accepted for Review by European Medicines Agency

Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) announced today that the European Medicines Agency (EMA) has...


Aug 25, 2016, 06:00 ET Egalet Announces Scientific Presentations at PAINWeek 2016 Meeting

 Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...


Aug 25, 2016, 04:00 ET The Largest and Longest Study of Patients with Schizophrenia Interacting with Digital Therapeutics Results Released

Pear Therapeutics (PEAR), the creator of prescription digital therapies called eFormulations™, announced today results from a real-world...


Aug 24, 2016, 15:48 ET Trialbee stärkt den Vorstand mit der Ernennung hochkarätiger Führungskräfte aus der Pharmabranche

Trialbee, ein junger Marktführer im Bereich E-Clinic-Lösungen, freut sich, die strategische Ernennung von Ulf Wiinberg als...


Aug 24, 2016, 10:35 ET US Phytotherapy Reports Successful pre-clinical testing of PROACT-D

US Phytotherapy, Inc. ("USPI"), today announced the successful completion of preclinical studies on PROACT-D, a novel therapeutic for the treatment...


Aug 24, 2016, 10:05 ET Promising Results From Molecular Dynamics' CZT Based Digital SPECT/CT Trial

Molecular Dynamics has successfully completed the first phase of a clinical trial to evaluate the Valiance X12 whole-body Cadmium Zinc Telluride...


Aug 24, 2016, 09:00 ET Novel Gene Therapy Drug for Huntington's Disease

Data from Vybion on a novel treatment for Huntington's disease has been published in the Journal of Neurodegenerative diseases. The published study...


Aug 24, 2016, 09:00 ET Trialbee Strengthens the Board of Directors With High Profile Appointments of Senior Executives From Pharmaceutical Industry

Trialbee, an emerging leader in e-clinical solutions is pleased to announce the strategic appointments of Ulf Wiinberg as Chairman of the Board...


Aug 24, 2016, 08:20 ET Seqirus Presents Integrated Analyses for Trivalent Adjuvanted Seasonal Influenza Vaccine for Young Children

Seqirus today announced results of two data integrated analyses from six randomized clinical trials evaluating the safety and immunogenicity of its...


Aug 24, 2016, 08:00 ET BioPharmX Enrolls First Subject in OPAL Phase 2b Clinical Trial of BPX-01 Topical Minocycline for the Treatment of Acne

 BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company developing products for the dermatology market, today announced...


Aug 24, 2016, 08:00 ET Data from Phase 3b ENSURE-AF Study Investigating Once-Daily SAVAYSA® (edoxaban) in Patients with Atrial Fibrillation Undergoing Cardioversion Among 13 Daiichi Sankyo Clinical Presentations at ESC Congress 2016

 Daiichi Sankyo, Inc. (hereafter, Daiichi Sankyo) today announced the presentation of 13 abstracts at the ESC Congress 2016, taking place from...


Aug 24, 2016, 08:00 ET RegeneRx Joint Venture to Begin Second Phase 3 Study Of RGN-259 for Dry Eye Syndrome in 3rd Quarter

 RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue...


Aug 24, 2016, 08:00 ET Creative Medical Technology Holdings Expands Adult Stem Cell Therapeutic Platform to Combat Female Infertility Caused by Premature Ovarian Failure

 Creative Medical Technology Holdings, Inc. (OTCQB: CELZ) announced the filing of a patent application disclosing means of regenerating failing...


Aug 24, 2016, 07:04 ET National MS Society and University of Iowa Launch $1 Million Clinical Trial to Test Dietary Approaches to Treating Fatigue in Multiple Sclerosis

 The National Multiple Sclerosis Society has just committed more than $1 million to support a clinical trial at the University of Iowa led by...


Aug 24, 2016, 07:00 ET SI-BONE, Inc. Announces Two-Year Results from a Randomized Controlled Trial of the iFuse Implant System® vs. Non-Surgical Management for Some Causes of Sacroiliac Joint Dysfunction

 SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System® ("iFuse"), a patented triangular-shaped...


Aug 23, 2016, 20:03 ET Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2016

Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, "Diabetic Neuropathic Pain Global...


Aug 23, 2016, 14:34 ET Penn Dental-led Team Uses Nanoparticles to Break Up Plaque and Prevent Cavities

 The bacteria in dental plaque that contribute to tooth decay often resist traditional antimicrobial treatment, as they can "hide" within a...


Aug 23, 2016, 13:00 ET Immune Therapeutics, Inc., Through Its Wholly Owned Subsidiary TNI BioTech International, Ltd., Initiates Clinical Trial In Malawi With LDN For The Prevention Of Cervical Cancer

Immune Therapeutics, Inc. (OTCQB-IMUN) ("IMUN"), headquartered in Orlando, Florida, is a clinical-stage biopharmaceutical company involved in the...